Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-03-22 @ 2:28 AM
Study NCT ID:
NCT01785160
Status:
COMPLETED
Last Update Posted:
2015-08-03
First Post:
2012-12-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigation of Faldaprevir Effect on Pharmacokinetics of Raltegravir
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1220.65
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None